2RAYMAN M P. The importance of selenium to human health [ J ]. Lancet,2000,356 (9225) :233-241.
3HURST R,HOOPER L, HORAT T, et al. Selenium and pros- tate cancer: systematic review and meta- analysis [ J ]. Am H Clin Nrtr,2012,96( 1 ) : 111 - 122.
4MUECKE R,KLOTZ T,GIEDL J,et al. Whole blood selenium levels (WBSL) in patients with prostate cancer ( PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels(PTSL) in patients with PC and BPH[ J ]. Acta Oncol,2009,48 (3) :452-456.
5MARTINEZ M E,JACOBS E T, BARON J A, et al. Dietary supplements and cancer prevention:balancing potential bene- fits against proven harms [ J]. J Natl Cancer Inst, 2012, 104 (10) :732-739.
6QU C X, KAMANGAR F, FAN J H, et al. Chemoprevention of primary liver cancer:a randomized, double-blind trial in Linx- ian, China[ J]. J Natl Cancer Inst, 2007,99 (16) : 1240-1247.
7TONG C, YIN Z, SONG Z, et al. c-Jun NI-I2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor sup- pression[ J ]. Am J Pathol,2007,171 ( 1 ) :297-303.
8GARCIA-CAZARIN M L, SMITH J L, CLAIR D K, et al. The alphalD-adrenergic receptor induces vascular smooth muscle apoptosis via a p53-dependent mechanism [ J ]. Mol Pharma- col ,2008,74(4 ) : 1000-1007.
9SELENIUS M, RUNDLOF A K, OLM E, et al. Selenium and the selenoprotein thioredoxin reductase in the prevention, treat- ment and diagnostics of cancer [ J ]. Antioxid Redox Signal, 2010,12 (7) :867-880.
10HUSBECK B, NONN L, PEEHL D M, et al. Tumor-selective killing by selenite in patient-matched pairs of normal and ma- lignant prostate cells [ J ]. Prostate, 2006,66 ( 2 ) : 218- 225.
